Novartis Investigative Site

Sao Paulo - SP 01323-900

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Thrombocytopaenia

Studies at this site

• Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma — Completed
• A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) — Stopped early